Who are the siloviki & what will their role be in a Medvedev administration?
Michael Idov is a contributing writer at New York Magazine and the editor-in-chief of RUSSIA!, an English-language quarterly highlighting Russian art and design. He moved to the U.S. from the former U.S.S.R. at the age of 16, settling in Cleveland before moving to New York. After a degree in film studies from the University of Michigan, Michael embarked on a series of odd jobs that included anchoring a Russian news program and owning a failed coffee house, and ended with his joining the staff of New York. His writing has appeared in outlets as diverse as Slate, Vogue, Pitchfork Media, NPR, the New Republic and (in his native Russian) Moscow's Bolshoi Gorod. Idov's on-and-off band Spielerfrau, playing what the New Yorker dubbed "sophisticated, reverb-drenched rock with intelligent lyrics," is set to release its second LP in April 2008. His first novel, "Ground Up," will be published in early 2009 by Farrar, Straus and Giroux.
Also known as "The Power Men."
A new study estimated the untapped potential of wind energy across Europe.
- A new report calculated how much electricity Europe could generate if it built onshore wind farms on all of its exploitable land.
- The results indicated that European onshore wind farms could supply the whole world with electricity from now until 2050.
- Wind farms come with a few complications, but the researchers noted that their study was meant to highlight the untapped potential of the renewable energy source in Europe.
French newspapers report that the trial hasn't lived up to expectations.
- The French government initially invested in a rural solar roadway in 2016.
- French newspapers report that the trial hasn't lived up to expectations.
- Solar panel "paved" roadways are proving to be inefficient and too expensive.
You want one. Now you may be able to survive one.
Photo credit: Jie Zhao / Getty contributor
- Cats live in a quarter of Western households.
- Allergies to them are common and can be dangerous.
- A new approach targets the primary trouble-causing allergen.